Capstan Medical — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Capstan Compass Robotic System for Transcatheter Mitral Valve ReplacementThis early feasibility study is evaluating the safety and performance of the Capstan Compass Robotic System™ for transcatheter mitral valve replacement in patients with symptomatic, moderate-to-severe or severe mitral regurgitation who are unsuitable for surgical repair or transcatheter edge-to-edge repair.	Maladie coronarienne	Non applicable	Traitement symptomatique	United States	À vérifier
Capstan Compass Robotic System for Transcatheter Mitral Valve ReplacementThis early feasibility study is evaluating the safety and performance of the Capstan Compass Robotic System™ for transcatheter mitral valve replacement in patients with symptomatic, moderate-to-severe or severe mitral regurgitation who are unsuitable for surgical repair or transcatheter edge-to-edge repair.	Maladie coronarienne	Non applicable	Traitement symptomatique	United States	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
Capstan Compass Robotic System for Transcatheter Mitral Valve Replacement	Maladie coronarienne	Non applicable	NCT07917208	Early Feasibility Study of the Capstan Medical TMVR System	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.